Traffic Fatalities Decline in States With Medical Marijuana Laws
Summary: Researchers report an average 11 percent reduction in traffic fatalities in states after enacting medical marijuana laws.
Source: Columbia University.
Key Findings
Researchers at Columbia University’s Mailman School of Public Health found that states adopting medical marijuana laws experienced measurable declines in traffic fatalities. On average, states that passed such laws saw an 11 percent drop in traffic deaths following enactment, and overall had traffic fatality rates roughly 26 percent lower than states without medical marijuana legislation. The study’s results were published in the American Journal of Public Health.
Age Groups Most Affected
The reductions were concentrated primarily among younger and middle-aged adults. The analysis found reductions in traffic fatalities by age group as follows: 11 percent among those aged 15 to 24, 12 percent among those aged 25 to 44, and 9 percent among drivers aged 45 and older. The decline was particularly notable for people aged 25 to 44, a demographic that represents a substantial share of medical marijuana program registrants.
Operational dispensaries—locations where medical marijuana was available for patients—were linked to an additional reduction in fatalities among 25- to 44-year-olds, estimated at about 5 percent. However, the evidence of reductions among people 45 and older was less consistent, suggesting that the primary mechanisms driving the overall decline operate more strongly among younger adults.
Possible Mechanisms and Context
Investigators suggested several possible explanations for the association between medical marijuana laws and lower traffic fatalities. One interpretation is that in some states the availability of medical marijuana may have reduced alcohol-impaired driving; the study reported lower self-reported rates of driving after “having too many drinks” in states with medical marijuana laws compared to those without. Other state-level factors—such as stronger traffic enforcement, public health interventions, road infrastructure, or differences in healthcare systems—could also contribute to the observed differences and likely interact with the effect of medical marijuana policy.
Julian Santaella-Tenorio, a doctoral student in Epidemiology at the Mailman School, noted that medical marijuana laws may influence younger adults, a group disproportionately involved in alcohol-related fatal crashes. For example, between 2004 and 2013, nearly half of drivers fatally injured with a blood alcohol concentration of 0.08 or greater were between 25 and 44 years old, highlighting the relevance of this age group for traffic-safety interventions.
Data and Methods
The analysis used data from the Fatality Analysis Reporting System (FARS), a nationwide census of fatal traffic crashes maintained by the National Highway Traffic Safety Administration. Researchers examined data covering 1985 through 2014 for all 50 states. During this period, about 1.22 million deaths were attributed to traffic crashes in the United States.
The study evaluated the association between each state’s medical marijuana laws and traffic fatalities for drivers, passengers, cyclists, and pedestrians. Researchers also assessed whether the presence of operational dispensaries correlated with changes in fatality rates. While many states with medical marijuana laws saw declines, results varied by state: a small number experienced increases in fatalities following enactment. For instance, California initially showed a 16 percent immediate reduction, and New Mexico showed an immediate 17.5 percent reduction, but both states later experienced gradual increases in fatality rates.
Heterogeneity and Need for Further Research
The authors stress that medical marijuana laws are heterogeneous across states and that implementation details, enforcement practices, and other local policies likely shape outcomes. These differences underline the need for further research into which specific elements of policy and practice produce beneficial effects, and how such laws interact with enforcement, public health measures, and underlying behavioral patterns like alcohol use.
Lead authors and collaborators on the study include researchers from Columbia University’s Mailman School of Public Health, the University of California, Davis, and Boston University. Co-authors listed by the study are June H. Kim, Julian Santaella-Tenorio, Christine M. Mauro, Julia Wrobel, Magdalena Cerdà, Katherine M. Keyes, Deborah S. Hasin, Silvia S. Martins, and Guohua Li.
Related Findings on Opioid Detection
The authors also analyzed whether operational medical marijuana laws were associated with the prevalence of opioids detected among fatally injured drivers. Using FARS data from 1999–2013 for 18 states that routinely tested drivers (n = 68,394), the combined state analysis did not show a statistically significant overall reduction in opioid positivity (odds ratio = 0.79; 95% CI = 0.61, 1.03). However, age-stratified results suggested a significant reduction for drivers aged 21 to 40 (odds ratio = 0.50; 95% CI = 0.37, 0.67), indicating that operational medical marijuana programs may be associated with lower opioid detection among younger fatally injured drivers and could potentially influence opioid use and overdose risk in that age group.
Funding and Acknowledgments
The research received support from the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the New York State Psychiatric Institute. Individual scholars received doctoral and fellowship support, including J. William Fulbright and national research grants acknowledged by the authors.
Original research: Study published in American Journal of Public Health. This article summarizes findings from that study and related analyses conducted by Columbia University investigators.